Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Patterns of Omalizumab in Chronic Urticaria Patients in China: A Retrospective Real-World Study

NCT07450170 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT07450170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07450170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Patterns of Omalizumab in Chronic Urticaria Patients in China: A Retrospective Real-World Study
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
March 10, 2026
Completion date
March 23, 2026
Enrollment
3,485 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic urticaria